CTC Diagnostics Global Markets Expected to Reach $10.3 Billion by 2022 WELLESLEY, Mass., April 25, 2018 (GLOBE NEWSWIRE) -- Increasing adoption of circulating tumor cell technologies (CTC), the increasing incidence of cancer and reimbursement support are driving growth...